PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0022P0180BLOOD TYPING reagents — Immucor, Inc

Immucor, Inc holds $8.2M across 217 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

W40m Mrc0 West

Awarding office

Immucor, Inc

Recipient

Sep 30, 2026

PoP end

$91K

Obligated

$228K

Potential

325413

NAICS

6550

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Immucor, Inc — $90

Contract facts

NONE

Contract numberW81K0022P0180

Also listed asW81K00-22-P-0180

AgencyW40m Mrc0 West

Awarding officeW40m Mrc0 West

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentImmucor, Inc

CAGE64527

UEIKV8AGJX7NMZ7

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Place of performanceEL PASO TX

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationW81K0022Q0141

PoP startOct 1, 2022

PoP end (current)Sep 30, 2026

PoP end (w/ options)Sep 30, 2027

Obligated$91K

Current value$183K

Potential value$228K

BLOOD TYPING REAGENTS. is a federal NONE award for W40m Mrc0 West held by Immucor, Inc. Estimated value $228K ($91K obligated). Current period of performance ends Sep 30, 2026 (potential Sep 30, 2027). Last award drew 1 bidder. Place of performance: EL PASO TX. Related solicitation W81K0022Q0141.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Immucor, Inc — $8.2M obligated across 217 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($8.2M) · all agencies

Department of Veterans Affairs (VA)$4.0M · 49%Department of Defense (DOD)$3.8M · 46%Department of Health and Human Services (HHS)$444K · 5%

Open full company profile →

Related awards

Same incumbent

N6890821F0035

SUPPLIES/SERVICES

$404K

Sep 30, 2026

36C24623P0063

BLOOD BANK REAGENTS AND CONSUMBLES

$237K

Sep 30, 2026

N0025922F0233

PANOCELL 16 16X3

$224K

Sep 30, 2026

75H71023F80334

EXERCISE OPTION

$224K

Jan 31, 2027

W81K0222P0068

REAGENTS AND USE OF ECHO LUMENA ANALYZER FOR BLOOD BANK - BASE PERIOD: 1 OCT 2022 - 30 SEP…

$1.4M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0022P0180?

W81K0022P0180 (BLOOD TYPING reagents) is a W40m Mrc0 West award with a potential value of $228K, currently held by Immucor, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K00-22-P-0180?

W81K00-22-P-0180 is the dashed form of PIID W81K0022P0180 (BLOOD TYPING reagents), held by Immucor, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0022P0180?

W40m Mrc0 West awarded W81K0022P0180 to Immucor, Inc (potential $228K).

Who is the incumbent on W81K0022P0180?

Immucor, Inc is the incumbent with $8.2M across 217 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Immucor, Inc’s W81K0022P0180 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Dec 18, 2025